Logo image of MGRX

MANGOCEUTICALS INC (MGRX) Stock Earnings & Estimates

NASDAQ:MGRX - US56270V2051 - Common Stock

1.73 USD
+0.07 (+4.22%)
Last: 8/22/2025, 8:24:14 PM
1.51 USD
-0.22 (-12.72%)
After Hours: 8/22/2025, 8:24:14 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
MGRX revenue by date.MGRX revenue by date.
8.9K731.5K
8,119.10%		615.9K
-15.80%
EBITDA
YoY % growth
MGRX ebitda by date.MGRX ebitda by date.
-1.988M
-11,258.29%		-9.194M
-362.54%		-7.962M
13.40%
EBIT
YoY % growth
MGRX ebit by date.MGRX ebit by date.
-1.992M
-11,280.57%		-9.219M
-362.89%		-8.694M
5.70%
Operating Margin
MGRX operating margin by date.MGRX operating margin by date.
-22,377.53%-1,260.27%-1,411.51%
EPS
YoY % growth
MGRX eps by date.MGRX eps by date.
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth		 109.3K
-48.95%		%
Q4 2024
Q2Q % growth		 105.3K
-56.91%		%
Q3 2024
Q2Q % growth		 133.4K
-45.60%		%
Q2 2024
Q2Q % growth		 163.2K
15.58%		%
Q1 2024
Q2Q % growth		 214.1K
112.61%		%
Q4 2023
Q2Q % growth		 244.4K
2,646.07%		%
MGRX Yearly Revenue VS EstimatesMGRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 200K 400K 600K
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A